Works matching AU Kupfer, Stuart

Results: 37

Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations.

Published in:

Heart Failure Reviews, 2015, v. 20, n. 4, p. 393, doi. 10.1007/s10741-015-9485-8

By:

Vaduganathan, Muthiah;
Butler, Javed;
Roessig, Lothar;
Fonarow, Gregg;
Greene, Stephen;
Metra, Marco;
Cotter, Gadi;
Kupfer, Stuart;
Zalewski, Andrew;
Sato, Naoki;
Filippatos, Gerasimos;
Gheorghiade, Mihai

Publication type:

Article

Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 664, doi. 10.1111/dom.12871

By:

Heller, Simon R.;
Bergenstal, Richard M.;
White, William B.;
Kupfer, Stuart;
Bakris, George L.;
Cushman, William C.;
Mehta, Cyrus R.;
Nissen, Steven E.;
Wilson, Craig A.;
Zannad, Faiez;
Liu, Yuyin;
Gourlie, Noah M.;
Cannon, Christopher P.

Publication type:

Article

Liver safety in patients with type 2 diabetes treated with pioglitazone: results from a 3-year, randomized, comparator-controlled study in the US.

Published in:

2009

By:

Tolman KG;
Freston JW;
Kupfer S;
Perez A;
Tolman, Keith G;
Freston, James W;
Kupfer, Stuart;
Perez, Alfonso

Publication type:

journal article

20. Major Cardiovascular Outcomes in the EXAMINE Trial According to ACE Inhibitor Use (12-OR).

Published in:

Nederlands Tijdschrift voor Diabetologie (NTvD), 2015, v. 13, n. 3, p. 75, doi. 10.1007/s12467-015-0041-x

By:

Serné, E.H. (Erik);
White, William B.;
Wilson, Craig A.;
Bakris, George L.;
Bergenstal, Richard M.;
Cannon, Christopher P.;
Cushman, William C.;
Fleck, Penny R.;
Heller, Simon R.;
Kupfer, Stuart;
Mehta, Cyrus R.;
Menon, Venu;
Nissen, Steven E.;
Perez, Alfonso T.;
Zannad, Faiez

Publication type:

Article

21. Cardiac Ischemic Outcomes and Hospitalizations in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome Treated with Alogliptin or Placebo: New Insights from the EXAMINE Trial (13-OR).

Published in:

Nederlands Tijdschrift voor Diabetologie (NTvD), 2015, v. 13, n. 3, p. 76, doi. 10.1007/s12467-015-0042-9

By:

Shimada, Yuichi J.;
Cannon, Christopher P.;
Wilson, Craig;
Nissen, Steven E.;
Kupfer, Stuart;
Zannad, Faeiz;
White, William B.

Publication type:

Article

Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.

Published in:

European Heart Journal, 2024, v. 45, n. 42, p. 4464, doi. 10.1093/eurheartj/ehae590

By:

Coats, Caroline J;
Masri, Ahmad;
Barriales-Villa, Roberto;
Abraham, Theodore P;
Brinkley, Douglas Marshall;
Claggett, Brian L;
Hagege, Albert;
Hegde, Sheila M;
Ho, Carolyn Y;
Kulac, Ian J;
Lee, Matthew M Y;
Maron, Martin S;
Olivotto, Iacopo;
Owens, Anjali T;
Solomon, Scott D;
Tfelt-Hansen, Jacob;
Watkins, Hugh;
Jacoby, Daniel L;
Heitner, Stephen B;
Kupfer, Stuart

Publication type:

Article

Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial.

Published in:

2016

By:

White, William B.;
Kupfer, Stuart;
Zannad, Faiez;
Mehta, Cyrus R.;
Wilson, Craig A.;
Lanyu Lei;
Bakris, George L.;
Nissen, Steven E.;
Cushman, William C.;
Heller, Simon R.;
Bergenstal, Richard M.;
Fleck, Penny R.;
Cannon, Christopher P.;
Lei, Lanyu;
EXAMINE Investigators

Publication type:

journal article

Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.

Published in:

2008

By:

Nissen SE;
Nicholls SJ;
Wolski K;
Nesto R;
Kupfer S;
Perez A;
Jure H;
De Larochellière R;
Staniloae CS;
Mavromatis K;
Saw J;
Hu B;
Lincoff AM;
Tuzcu EM;
PERISCOPE Investigators;
Nissen, Steven E;
Nicholls, Stephen J;
Wolski, Kathy;
Nesto, Richard;
Kupfer, Stuart

Publication type:

journal article

Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes.

Published in:

JAMA: Journal of the American Medical Association, 2008, v. 299, n. 13, p. 1561, doi. 10.1001/jama.299.13.1561

By:

Nissen, Steven E.;
Nicholls, Stephen J.;
Wolski, Kathy;
Nesto, Richard;
Kupfer, Stuart;
Perez, Alfonso;
Jure, Horacio;
De Larochellière, Robert;
Staniloae, Cezar S.;
Mavromatis, Kreton;
Saw, Jacqueline;
Hu, Bo;
Lincoff, A. Michael;
Tuzcu, E. Murat

Publication type:

Article

Plasma neurofilament analysis in VITALITY-ALS.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2025, v. 26, n. 1/2, p. 103, doi. 10.1080/21678421.2024.2423707

By:

Simkins, Tyrell J.;
Kupfer, Stuart;
Malik, Fady I.;
Meng, Lisa;
Rudnicki, Stacy A.;
Wei, Jenny;
Shefner, Jeremy M.;
Bowser, Robert

Publication type:

Article

Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2024, v. 25, n. 1/2, p. 162, doi. 10.1080/21678421.2023.2252468

By:

Shefner, Jeremy M.;
Jacobsen, Bill;
Kupfer, Stuart;
Malik, Fady I.;
Meng, Lisa;
Wei, Jenny;
Wolff, Andrew A;
Rudnicki, Stacy A.

Publication type:

Article

Effects of pioglitazone on lipid and lipoprotein profiles in patients with type 2 diabetes and dyslipidaemia after treatment conversion from rosiglitazone while continuing stable statin therapy.

Published in:

Diabetes & Vascular Disease Research, 2006, v. 3, n. 1, p. 39, doi. 10.3132/dvdr.2006.005

By:

Berhanu, Paulos;
Kipnes, Mark S;
Khan, Mehmood A;
Perez, Alfonso T;
Kupfer, Stuart F;
Spanheimer, Robert G;
Demissie, Seleshi;
Fleck, Penny R

Publication type:

Article

CD44 Antibodies Inhibit Osteoclast Formation.

Published in:

Journal of Bone & Mineral Research, 1997, v. 12, n. 8, p. 1155, doi. 10.1359/jbmr.1997.12.8.1155

By:

Kania, Janice R.;
Kehat-Stadler, Talia;
Kupfer, Stuart R.

Publication type:

Article

Efficacy and safety of azilsartan medoxomil/chlortalidone fixed-dose combination in hypertensive patients uncontrolled on azilsartan medoxomil alone: A randomized trial.

Published in:

2018

By:

Collier, David J.;
Juhasz, Attila;
Agabiti‐Rosei, Enrico;
Lloyd, Eric;
Hisada, Michie;
Zhao, Lin;
Kupfer, Stuart;
Caulfield, Mark J.;
Agabiti-Rosei, Enrico

Publication type:

journal article

Long-term efficacy and tolerability of azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide in chronic kidney disease.

Published in:

2018

By:

Bakris, George L.;
Zhao, Lin;
Kupfer, Stuart;
Juhasz, Attila;
Hisada, Michie;
Lloyd, Eric;
Oparil, Suzanne

Publication type:

journal article

Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African-American patients with hypertension.

Published in:

2017

By:

Johnson, Wallace;
White, William B.;
Sica, Domenic;
Bakris, George L.;
Weber, Michael A.;
Handley, Alison;
Perez, Alfonso;
Cao, Charlie;
Kupfer, Stuart;
Saunders, Elijah B.

Publication type:

journal article

Blood Pressure-Lowering Efficacy of the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone: A Factorial Study.

Published in:

Journal of Clinical Hypertension, 2012, v. 14, n. 5, p. 284, doi. 10.1111/j.1751-7176.2012.00616.x

By:

Sica, Domenic;
Bakris, George L.;
White, William B.;
Weber, Michael A.;
Cushman, William C.;
Huang, Patrick;
Roberts, Andrew;
Kupfer, Stuart

Publication type:

Article

Comparison of the Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil vs Valsartan by Ambulatory Blood Pressure Monitoring.

Published in:

Journal of Clinical Hypertension, 2011, v. 13, n. 7, p. 467, doi. 10.1111/j.1751-7176.2011.00482.x

By:

Sica, Domenic;
White, William B.;
Weber, Michael A.;
Bakris, George L.;
Perez, Alfonso;
Cao, Charlie;
Handley, Alison;
Kupfer, Stuart

Publication type:

Article

The Comparative Effects of Azilsartan Medoxomil and Olmesartan on Ambulatory and Clinic Blood Pressure.

Published in:

Journal of Clinical Hypertension, 2011, v. 13, n. 2, p. 81, doi. 10.1111/j.1751-7176.2010.00425.x

By:

Bakris, George L.;
Sica, Domenic;
Weber, Michael;
White, William B.;
Roberts, Andrew;
Perez, Alfonso;
Cao, Charlie;
Kupfer, Stuart

Publication type:

Article

A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes.

Published in:

Pharmacoepidemiology & Drug Safety, 2007, v. 16, n. 12, p. 1314, doi. 10.1002/pds.1497

By:

Gerrits, Charles M.;
Bhattacharya, Mondira;
Manthena, Shivaji;
Baran, Robert;
Perez, Alfonso;
Kupfer, Stuart

Publication type:

Article

A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes.

Published in:

Pharmacoepidemiology & Drug Safety, 2007, v. 16, n. 10, p. 1065, doi. 10.1002/pds.1470

By:

Gerrits, Charles M.;
Bhattacharya, Mondira;
Manthena, Shivaji;
Baran, Robert;
Perez, Alfonso;
Kupfer, Stuart

Publication type:

Article

Dual Therapy in Hypertensive Patients with Coronary Artery Disease: The Role of Calcium Channel Blockers and Î²-Blockers.

Published in:

American Journal of Cardiovascular Drugs, 2007, v. 7, p. 25, doi. 10.2165/00129784-200707001-00004

By:

Bakris, George L.;
Cooper-DeHoff, Rhonda M.;
Qian Zhou;
Kupfer, Stuart;
Champion, Annette;
Pepine, Carl J.

Publication type:

Article

Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten: Aficamten in Hepatic or Renal Impairment: D. Xu et al.

Published in:

Clinical Pharmacokinetics, 2025, v. 64, n. 3, p. 397, doi. 10.1007/s40262-025-01481-9

By:

Xu, Donghong;
Lutz, Justin D.;
Divanji, Punag;
Li, Jianlin;
Benattia, Youcef;
Griffith, Adrienne;
Heitner, Stephen B.;
Kupfer, Stuart;
German, Polina

Publication type:

Article

Clinical Evaluation of the Effect of Aficamten on QT/QTc Interval in Healthy Participants.

Published in:

CTS: Clinical & Translational Science, 2025, v. 18, n. 4, p. 1, doi. 10.1111/cts.70218

By:

Maharao, Neha;
Xu, Donghong;
Simkins, Tyrell J.;
Bowles, Owen;
Liu, Genzhou;
Benattia, Youcef;
Griffith, Adrienne;
Heitner, Stephen B.;
Kupfer, Stuart;
German, Polina

Publication type:

Article

A Drug Dose Model for Predicting Clinical Outcomes in Hypertensive Coronary Disease Patients.

Published in:

Journal of Clinical Hypertension, 2005, v. 7, n. 11, p. 654, doi. 10.1111/j.1524-6175.2005.04800.x

By:

Elliott, William J.;
Hewkin, Ann C.;
Kupfer, Stuart;
Cooper-DeHoff, Rhonda;
Pepine, Carl J.

Publication type:

Article

Glycemic Efficacy of Concomitant Administration of Pioglitazone with the Extended-Release Metformin Fortamet.

Published in:

Diabetes, 2007, v. 56, p. A565

By:

Kupfer, Stuart;
Perez, Alfonso;
Cao, Charlie;
Munshi, Mahtab

Publication type:

Article

Effects of 30 mg of Pioglitazone vs 4 mg of Rosiglitazone on Hyperglycemia and Dyslipidemia: Results from GLAI.

Published in:

Diabetes, 2007, v. 56, p. A542

By:

Kupfer, Stuart;
Spanheimer, Robert;
Jacober, Scott;
Tan, Meng;
Gbenado, Seth

Publication type:

Article

Effects of Pioglitazone and Rosiglitazone on Diabetic Dyslipidemia by Gender: Results from GLAI.

Published in:

Diabetes, 2007, v. 56, p. A236

By:

Perez, Alfonso;
Kupfer, Stuart;
Tan, Meng;
Jacober, Scott;
Gbenado, Seth

Publication type:

Article

Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial.

Published in:

2022

By:

Lewis, Gregory D.;
Voors, Adriaan A.;
Cohen-Solal, Alain;
Metra, Marco;
Whellan, David J.;
Ezekowitz, Justin A.;
Böhm, Michael;
Teerlink, John R.;
Docherty, Kieran F.;
Lopes, Renato D.;
Divanji, Punag H.;
Heitner, Stephen B.;
Kupfer, Stuart;
Malik, Fady I.;
Meng, Lisa;
Wohltman, Amy;
Felker, G. Michael

Publication type:

journal article

Long-term Safety of Pioglitazone versus Glyburide in Patients with Recently Diagnosed Type 2 Diabetes Mellitus.

Published in:

Pharmacotherapy, 2006, v. 26, n. 10, p. 1388, doi. 10.1592/phco.26.10.1388

By:

Jain, Rajeev;
Osei, Kwame;
Kupfer, Stuart;
Perez, Alfonso T.;
Zhang, Jeff

Publication type:

Article

Safety and efficacy of aficamten in patients with non‐obstructive hypertrophic cardiomyopathy: A 36‐week analysis from FOREST‐HCM.

Published in:

European Journal of Heart Failure, 2024, v. 26, n. 9, p. 1993, doi. 10.1002/ejhf.3372

By:

Masri, Ahmad;
Barriales‐Villa, Roberto;
Elliott, Perry;
Nassif, Michael E.;
Oreziak, Artur;
Owens, Anjali T.;
Tower‐Rader, Albree;
Heitner, Stephen B.;
Kupfer, Stuart;
Malik, Fady I.;
Melloni, Chiara;
Meng, Lisa;
Wei, Jenny;
Saberi, Sara

Publication type:

Article

Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N‐terminal pro‐B‐type natriuretic peptide level: insights from the GALACTIC‐HF trial.

Published in:

European Journal of Heart Failure, 2023, v. 25, n. 2, p. 248, doi. 10.1002/ejhf.2763

By:

Docherty, Kieran F.;
McMurray, John J.V.;
Claggett, Brian L.;
Miao, Zi Michael;
Adams, Kirkwood F.;
Arias‐Mendoza, Alexandra;
Cleland, John G.F.;
Diaz, Rafael;
Echeverria Correa, Luis E;
Felker, G. Michael;
Fonseca, Candida;
Li, Jing;
Metra, Marco;
Sliwa‐Hahnle, Karen;
Solomon, Scott D.;
Vandekerckhove, Hans J.;
Vinereanu, Dragos;
Voors, Adriaan A.;
Heitner, Stephen B.;
Kupfer, Stuart

Publication type:

Article

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.

Published in:

European Journal of Heart Failure, 2013, v. 15, n. 10, p. 1082, doi. 10.1093/eurjhf/hft095

By:

Zannad, Faiez;
Garcia, Angeles Alonso;
Anker, Stefan D.;
Armstrong, Paul W.;
Calvo, Gonzalo;
Cleland, John G.F.;
Cohn, Jay N.;
Dickstein, Kenneth;
Domanski, Michael J.;
Ekman, Inger;
Filippatos, Gerasimos S.;
Gheorghiade, Mihai;
Hernandez, Adrian F.;
Jaarsma, Tiny;
Koglin, Joerg;
Konstam, Marvin;
Kupfer, Stuart;
Maggioni, Aldo P.;
Mebazaa, Alexandre;
Metra, Marco

Publication type:

Article

Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous?

Published in:

Annals of Internal Medicine, 2006, v. 144, n. 12, p. 884, doi. 10.7326/0003-4819-144-12-200606200-00005

By:

Messerli, Franz H.;
Mancia, Giuseppe;
Conti, C. Richard;
Hewkin, Ann C.;
Kupfer, Stuart;
Champion, Annette;
Kolloch, Rainer;
Benetos, Athanase;
Pepine, Carl J.

Publication type:

Article

Population Pharmacokinetics and Exposure-Response of a Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With Stage 2 Hypertension.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 8, p. 988, doi. 10.1002/jcph.684

By:

Tsai, Max C.;
Wu, Jingtao;
Kupfer, Stuart;
Vakilynejad, Majid

Publication type:

Article

Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial.

Published in:

European Heart Journal, 2022, v. 43, n. 48, p. 5006, doi. 10.1093/eurheartj/ehac293

By:

Metra, Marco;
Pagnesi, Matteo;
Claggett, Brian L;
Díaz, Rafael;
Felker, G Michael;
McMurray, John J V;
Solomon, Scott D;
Bonderman, Diana;
Fang, James C;
Fonseca, Cândida;
Goncalvesova, Eva;
Howlett, Jonathan G;
Li, Jing;
O'Meara, Eileen;
Miao, Zi Michael;
Abbasi, Siddique A;
Heitner, Stephen B;
Kupfer, Stuart;
Malik, Fady I;
Teerlink, John R

Publication type:

Article

Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.

Published in:

European Heart Journal, 2022, v. 43, n. 23, p. 2212, doi. 10.1093/eurheartj/ehac144

By:

Solomon, Scott D;
Claggett, Brian L;
Miao, Zi Michael;
Diaz, Rafael;
Felker, G Michael;
McMurray, John J V;
Metra, Marco;
Corbalan, Ramon;
Filippatos, Gerasimos;
Goudev, Assen R;
Mareev, Viatcheslav;
Serpytis, Pranas;
Suter, Thomas;
Yilmaz, Mehmet B;
Zannad, Faiez;
Kupfer, Stuart;
Heitner, Stephen B;
Malik, Fady I;
Teerlink, John R

Publication type:

Article